Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12428403
N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists
granted -
US 12419890
Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors
granted -
US 12421188
Heterocyclic compound and use thereof
granted -
US 12415782
Heterocyclic compound and use thereof
granted -
US 12415866
Monoclonal antibody inhibitor of Factor XIIa
granted -
US 12409210
CNS delivery of therapeutic agents
granted -
US 12403154
Administration of sting agonist and checkpoint inhibitors
granted -
US 12404237
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives
granted -
US 12391760
Method of treating primary sclerosing cholangitis
granted -
US 12391765
Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies
granted -
US 12391739
Method for producing gamma delta T cells
granted -
US 12384854
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
granted -
US 12383587
AAV triple-plasmid system
granted -
US 12384770
Heterocyclic compound
granted -
US 12377078
Viral inhibitors, the synthesis thereof, and intermediates thereto
granted -
US 12378256
Heterocyclic compound
granted -
US 12370192
Azole-fused pyridazin-3(2H)-one derivatives
granted -
US 12371506
Subcutaneous administration of anti-CD38 antibodies
granted -
US 12365723
Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS
granted -
US 12364791
Conformal coating of biological surfaces
granted -
US 12358879
Heterocyclic compound
granted -
US 12359178
Methods and compositions for treatment of hunter syndrome comprising iduronate-2-sulfatase
granted -
US 12351824
Method for producing natural killer cells from pluripotent stem cells
granted -
US 12337020
Bacteriophage compositions
granted